Changes and Prognostic Value of Serum Vascular Endothelial Growth Factor in Patients with Differentiated Thyroid Cancer

OBJECTIVE: To evaluate the changes and the prognostic value of serum vascular endothelial growth factor (VEGF) in patients with differentiated thyroid cancer (DTC). SUBJECTS AND METHODS: A total of 79 patients with DTC and 30 healthy individuals were divided into four groups: (1) a healthy control g...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zhen-Hu, Cui, Xiao-Ning, Xing, Huai-Guang, Yan, Rui-Hong, Yao, Dao-Kuo, Wang, Le-Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2012
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586707/
https://www.ncbi.nlm.nih.gov/pubmed/22890443
http://dx.doi.org/10.1159/000340051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586707/
https://www.ncbi.nlm.nih.gov/pubmed/22890443
http://dx.doi.org/10.1159/000340051

Ejemplares similares